BOSTON (PRWEB) July 25, 2018
Boston Biotech Conferences will host BD Boston, an invitation-only, off-the-record meeting for C-level biopharma executives on September 4, 2018 at The Hilton Boston Back Bay Hotel. This peer-to-peer meeting provides an opportunity for industry leaders to leverage insight from real-life business development experiences and dissect the most relevant deals in biotech.
George Golumbeski recently joined GRAIL with more than 25 years of experience in the biotechnology industry. He currently serves on the Board of Directors at KSQ Therapeutics, Carrick Therapeutics, Enanta Pharmaceuticals, and MorphoSys. Dr. Golumbeski was most recently Executive Vice President of Business Development for Celgene, where he was responsible for forging collaborations with biotechnology companies seeking to bring breakthrough medications to people suffering from cancer and chronic inflammation.
To attend, please register here.
ABOUT BOSTON BIOTECH CONFERENCES:
Boston Biotech Conferences are exclusive, thought-leader forums for senior biopharma executives. Each conference is highly interactive and co-hosted by healthcare industry leaders to foster discussions and facilitate information-sharing, networking and corporate development within the biopharma community. These meetings convene the most relevant players in biotech to network, forge partnerships and leverage the experiences of their peers in an off-the-record setting. For more information, please visit: http://www.bostonbiotechconferences.com
Boston Biotech Conferences
Suzanne Carroll: email@example.com
Nicole Hayes: firstname.lastname@example.org